Trial Profile

First phase III study of BUPI for pain management in oral mucositis in cancer patients

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 12 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bupivacaine (Primary)
Indications Pain
Focus Registrational; Therapeutic Use

Most Recent Events

05 Nov 2020 According to a Moberg Pharma media release, this clinical phase 3 study can serve as the basis for registration in the European market as well as additional markets. The phase 3 study is expected to commence early in 2022 with the results obtained in 2023.
10 May 2016 According to Moberg media release, company will start enrollment of patients for this study in the first half of 2017.
28 Mar 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com